GlassScriptPhysician profile
George Tokodi
NPI 1215933700
$2,071.40
in general payments reported to CMS, 2019-2025
28 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $540 · 2020: $288 · 2021: $328 · 2022: $467 · 2023: $200 · 2024: $130 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $432 · Education: $18.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $431.73 |
| Education | $18.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $261.05 | 2021-2024 | Dalvance |
| Ferring Pharmaceuticals INC. | $202.31 | 2019-2024 | Euflexxa |
| Depuy Synthes Sales INC. | $178.36 | 2019-2022 | |
| Pacira Therapeutics, INC. | $157.15 | 2019-2021 | |
| Vericel Corporation | $138.87 | 2019 | |
| Endo Pharmaceuticals INC. | $136.37 | 2019-2024 | Xiaflex |
| Stryker Corporation | $115.57 | 2022-2025 | Axsos, Hoffmann, Variax |
| Zimmer Biomet Holdings, INC. | $99.34 | 2022 | |
| Allergan, INC. | $88.37 | 2019-2020 | |
| Smith+Nephew, INC. | $83.04 | 2019-2025 | "Acticoat 4"" X 4""", Renasys Go V2 Home, Pico 7 |
| Davol INC. | $75.49 | 2022 | |
| Bioventus LLC | $74.33 | 2019-2024 | Exogen Ultrasound Bone Healing System |
| Vertex Pharmaceuticals Incorporated | $72.03 | 2024-2025 | |
| Horizon Therapeutics Plc | $48.68 | 2019-2020 | |
| Becton, Dickinson and Company | $46.06 | 2023-2025 | Arista Ah Flexitip, Arista |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultragenyx Pharmaceutical INC. | $40.62 | 2021-2022 | |
| Checkpoint Surgical, INC | $29.80 | 2020-2023 | Checkpoint Stimulators |
| Medtronic, INC. | $29.72 | 2021-2023 | Aquamantys(Tm) |
| Avanos Medical | $29.54 | 2024 | Trivisc Sodium Hyaluronate |
| Orthogenrx INC. | $28.90 | 2019 | |
| Kci USA, INC. | $23.62 | 2021 | |
| Heron Therapeutics, INC. | $23.43 | 2021-2022 | |
| Daiichi Sankyo INC. | $22.45 | 2022 | |
| Sonex Health, INC. | $17.15 | 2020 | |
| Medtronic USA, INC. | $14.69 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $14.29 | 2019 | |
| Amgen INC. | $11.25 | 2019 | |
| Heraeus Medical, LLC. | $8.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Tokodi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.